Graham Capital Management L.P. Buys 42,010 Shares of Pediatrix Medical Group, Inc. $MD

Key Points

• Graham Capital Management L.P. increased its stake in Pediatrix Medical Group by 119.0% in the first quarter, acquiring a total of 77,309 shares worth approximately $1.12 million.
• Brokerages have given Pediatrix Medical Group a consensus rating of "Moderate Buy" with an average target price of $16.75, with Zacks Research upgrading their rating to "strong-buy."
• Pediatrix Medical Group reported $0.53 earnings per share (EPS) for the latest quarter, exceeding analysts' expectations and reflecting a 7.1% decline in revenue compared to the previous year.

Graham Capital Management L.P. grew its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 119.0% in the first quarter, according to its most recent filing with the SEC. The institutional investor owned 77,309 shares of the company's stock after purchasing an additional 42,010 shares during the period. Graham Capital Management L.P. owned about 0.09% of Pediatrix Medical Group worth $1,120,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Nuveen LLC purchased a new position in shares of Pediatrix Medical Group during the first quarter valued at approximately $8,024,000. Nomura Holdings Inc. bought a new stake in Pediatrix Medical Group in the 4th quarter worth approximately $3,882,000. Nuveen Asset Management LLC grew its position in Pediatrix Medical Group by 110.8% in the 4th quarter. Nuveen Asset Management LLC now owns 485,587 shares of the company's stock worth $6,371,000 after purchasing an additional 255,273 shares during the period. Teacher Retirement System of Texas grew its position in Pediatrix Medical Group by 92.3% in the 1st quarter. Teacher Retirement System of Texas now owns 371,756 shares of the company's stock worth $5,387,000 after purchasing an additional 178,386 shares during the period. Finally, Northern Trust Corp grew its position in shares of Pediatrix Medical Group by 18.0% during the 4th quarter. Northern Trust Corp now owns 966,347 shares of the company's stock valued at $12,678,000 after acquiring an additional 147,522 shares during the period. 97.71% of the stock is owned by institutional investors.

Pediatrix Medical Group Stock Down 0.0%

MD traded down $0.01 during trading hours on Monday, hitting $17.06. 379,607 shares of the company's stock were exchanged, compared to its average volume of 757,304. The company has a current ratio of 1.80, a quick ratio of 1.80 and a debt-to-equity ratio of 0.70. Pediatrix Medical Group, Inc. has a 12-month low of $10.06 and a 12-month high of $17.67. The firm has a market cap of $1.49 billion, a P/E ratio of 13.24 and a beta of 1.29. The firm has a 50 day moving average of $14.46 and a 200 day moving average of $14.11.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $0.53 EPS for the quarter, topping analysts' consensus estimates of $0.42 by $0.11. Pediatrix Medical Group had a net margin of 5.66% and a return on equity of 18.94%. The company had revenue of $468.84 million during the quarter, compared to the consensus estimate of $464.37 million. During the same quarter in the prior year, the firm earned $0.34 EPS. Pediatrix Medical Group's quarterly revenue was down 7.1% on a year-over-year basis. Analysts predict that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on the stock. Leerink Partners boosted their price objective on shares of Pediatrix Medical Group from $14.50 to $17.00 and gave the company a "market perform" rating in a research report on Friday. Zacks Research upgraded shares of Pediatrix Medical Group to a "strong-buy" rating in a research report on Monday, August 11th. Finally, UBS Group upped their price target on shares of Pediatrix Medical Group from $16.00 to $16.50 and gave the company a "neutral" rating in a report on Thursday, August 14th. One analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat, Pediatrix Medical Group presently has an average rating of "Moderate Buy" and a consensus price target of $16.79.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.